Humana Inc.'s stock rose more than 7% following Bernstein's increase of its price target from $182 to $254, reflecting strong investor confidence. This boost in share price comes on the heels of the company's impressive Q1 earnings, which exceeded expectations, reinforcing its financial strength with a market cap of $36.18 billion. Additionally, Humana has expanded its Medicare Advantage coverage, a strategic move aimed at enhancing its competitive edge in the healthcare sector.
“Humana · received a · price target · $254”
“Humana · previous price target was · $182”
“Humana · had a Q1 earnings · beat”
“Humana · stock · price target raise · to $254 from $182”
“Humana · closed · up more than +7%”
“Humana · closed up · more than +7%”
“Humana · closed up · percentage · +7%”
“Humana · closed up · percentage · more than +7%”
“Humana · closed · up · more than +7%”
“Humana (HUM) · closed · up · more than +7%”
“Humana · closed · up · more than +7%”
“Humana (HUM) · closed · up · more than +7%”